Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Pleural Diseases 2Lung Neoplasms 2Recurrent Head and Neck Carcinoma 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Mesothelioma, Malignant 1Meningioma 1Medulloblastoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Germinoma 1Ependymoma 1Craniopharyngioma 1Chordoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Trioxsalen 2Photochemotherapy 2Dihematoporphyrin Ether 21-phenyl-3,3-dimethyltriazene 2Tyrosine Kinase Inhibitors 1Thoracic Surgery, Video-Assisted 1Phototherapy 1Dasatinib 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Pleural Diseases × Dihematoporphyrin Ether × Clear all
NCT03678350 2026-03-27

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Roswell Park Cancer Institute

Phase 1 Completed
9 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Pleural Diseases

NCT04836429 2026-02-04

Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

Roswell Park Cancer Institute

Phase 1 Terminated
5 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡